Moroctocog alfa Recruiting Phase 1 Trials for Hemophilia A Prevention

IndicationsStatusPurposePhase
RecruitingPrevention1
clinicaltrials.gov IdentifierTitleDrugs
NCT04060836Pharmacokinetics Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A.